Hasil Pencarian (1)
small molecule | CAS: 1374248-81-3
Atogepant is an oral antagonist of calcitonin gene-related peptide (CGRP) receptors indicated for the prevention of episodic migraine headaches. It was developed by AbbVie and received FDA approval under the brand name Qulipta in September 2021.[L38814] While…
Kategori:
AnalgesicsAntimigraine PreparationsBCRP/ABCG2 Substrates
+14
Target Protein:
Calcitonin gene-related peptide type 1 receptor
Waktu ParuhThe elimination hal…
Vol. DistribusiThe mean apparent v…
KlirensThe mean apparent o…
Genetik
-